CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

A pair of investor calls on Jan. 22 added clarity to the rapidly evolving cardiac ablation market with Abbott Laboratories and Johnson & Johnson providing updates on their pulsed field ablation ...

In 2024, Abbott's EP business demonstrated strength thanks to its preferred mapping systems, even though it is late to market with its own pulsed field ablation technology. However, EP growth ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

was used with the Abbott TactiCath™ Sensor Enabled, Boston Scientific INTELLANAV STABLEPOINT™, and Johnson & Johnson THERMOCOOL SMARTTOUCH™ ablation catheters. Paroxysmal and persistent AF ...